Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2095942 Target Snapshot

Cyclin-dependent kinase 4/cyclin D · PROTEIN COMPLEX GROUP · Homo sapiens

160Compounds
15Assays
1Approved Drugs
165.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P11802. Use UniProt P11802 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P11802 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cyclin-dependent kinase 4/cyclin D as ChEMBL target CHEMBL2095942, mapped to UniProt P11802. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cyclin-dependent kinase 4/cyclin D
PROTEIN COMPLEX GROUP · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2095942
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P11802
Cyclin-dependent kinase 4
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cyclin-dependent kinase 4/cyclin D is the right protein anchor across sources, using UniProt P11802 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCyclin-dependent kinase 4
UniProt AccessionP11802
Component TypeProtein
Sequence Length303 aa

Cyclin-dependent kinase 4

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cyclin-dependent kinase 4/cyclin D, mapped to UniProt P11802. ChEMBL maps the protein component as Cyclin-dependent kinase 4. Sequence length is 303 aa.

Mapped IDP11802
Review nameCyclin-dependent kinase 4/cyclin D
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
1
Phase I
Assay Mix

Activity Type Distribution

IC50165.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL142619 9.15 IC50 0.7 Preclinical
CHEMBL190281 8.7 IC50 2.0 Preclinical
CHEMBL365847 8.7 IC50 2.0 Preclinical
CHEMBL140808 8.4 IC50 4.0 Preclinical
CHEMBL141018 8.4 IC50 4.0 Preclinical
CHEMBL370295 8.4 IC50 4.0 Preclinical
CHEMBL426818 8.4 IC50 4.0 Preclinical
CHEMBL189937 8.3 IC50 5.0 Preclinical
CHEMBL190460 8.3 IC50 5.0 Preclinical
CHEMBL190627 8.3 IC50 5.0 Preclinical
Distribution

pChEMBL Value Distribution

9
5.0
19
5.5
19
6.0
31
6.5
19
7.0
29
7.5
19
8.0
3
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

PALBOCICLIB
CHEMBL189963
Approved 2015
Assay Landscape

Assay Landscape

15
Total Assays
146
Tested Compounds
1
Assay Types
Binding — 15 assays, 146 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 15 146 6.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine